Search research articles
Contact Us
Filters
Showing results (31-40 of 168) with videos related to
Page
of 17
Sort By:
Cell Reports
|
March 22, 2016
NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia
Jessica N Nichol, Matthew D Galbraith, Claudia L Kleinman, et al.
Blood
|
September 20, 2002
Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells
Sylvie Côté, Angelika Rosenauer, Andrea Bianchini, et al.
Elife
|
January 31, 2023
The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses
Parker Tope, Eliya Farah, Rami Ali, et al.
Leukemia Research
|
February 2, 2011
Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy
Lilian Amrein, David Davidson, May Shawi, et al.
Oncogene
|
November 2, 2004
Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism
Sonia V del Rincón, Qi Guo, Catia Morelli, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 29, 2003
The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells
Caroline Rousseau, Filippa Pettersson, Marie Claude Couture, et al.
Plos One
|
January 7, 2014
Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer
Cynthia Guilbert, Matthew G Annis, Zhifeng Dong, et al.
Investigational New Drugs
|
September 14, 2024
A phase 1b study of the ERK inhibitor MK-8353 plus pembrolizumab in patients with advanced solid tumors
Nehal J Lakhani, Howard Burris, Wilson H Miller, et al.
Cancer Research
|
June 20, 2019
A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy
Rakesh Kumar, Marc Van de Vijver, Giampaolo Tortora, et al.
Nature Reviews. Clinical Oncology
|
April 5, 2020
Moving towards personalized treatments of immune-related adverse events
Khashayar Esfahani, Arielle Elkrief, Cassandra Calabrese, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 168) with videos related to
Sort By:
Page
of 17
Cell Reports
|
March 22, 2016
NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia
Jessica N Nichol, Matthew D Galbraith, Claudia L Kleinman, et al.
Blood
|
September 20, 2002
Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells
Sylvie Côté, Angelika Rosenauer, Andrea Bianchini, et al.
Elife
|
January 31, 2023
The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses
Parker Tope, Eliya Farah, Rami Ali, et al.
Leukemia Research
|
February 2, 2011
Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy
Lilian Amrein, David Davidson, May Shawi, et al.
Oncogene
|
November 2, 2004
Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism
Sonia V del Rincón, Qi Guo, Catia Morelli, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
August 29, 2003
The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells
Caroline Rousseau, Filippa Pettersson, Marie Claude Couture, et al.
Plos One
|
January 7, 2014
Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer
Cynthia Guilbert, Matthew G Annis, Zhifeng Dong, et al.
Investigational New Drugs
|
September 14, 2024
A phase 1b study of the ERK inhibitor MK-8353 plus pembrolizumab in patients with advanced solid tumors
Nehal J Lakhani, Howard Burris, Wilson H Miller, et al.
Cancer Research
|
June 20, 2019
A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy
Rakesh Kumar, Marc Van de Vijver, Giampaolo Tortora, et al.
Nature Reviews. Clinical Oncology
|
April 5, 2020
Moving towards personalized treatments of immune-related adverse events
Khashayar Esfahani, Arielle Elkrief, Cassandra Calabrese, et al.
Page
of 17